Literature DB >> 31682235

Correction for: LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice.

Marco Malavolta1, Serena Dato2, Francesco Villa3, Francesco De Rango2, Francesca Iannone2, Anna Ferrario3, Anna Maciag3, Elena Ciaglia4, Antonio D'amato5, Albino Carrizzo5, Andrea Basso1, Fiorenza Orlando6, Mauro Provinciali1,6, Paolo Madeddu7, Giuseppe Passarino2, Carmine Vecchione4,5, Giuseppina Rose2, Annibale A Puca3,4.   

Abstract

Entities:  

Keywords:  correction

Year:  2019        PMID： 31682235      PMCID： PMC6834397          DOI： 10.18632/aging.102398

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN： 1945-4589            Impact factor:   5.682


× No keyword cloud information.
This article has been corrected:  The authors requested to add missing funding information for author M.P omitted by mistake. The authors declare that this correction does not change the results or conclusions of this paper. The updated Funding information is provided below, the added sentence is marked in bold. Original article: Aging. 2019; 11:6555–6568. https://doi.org/10.18632/aging.102209
  2 in total

Review 1.  Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy.

Authors:  Sakulrat Mankhong; Sujin Kim; Sohee Moon; Hyo-Bum Kwak; Dong-Ho Park; Ju-Hee Kang
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

2.  Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38+ macrophages and NAD+ decline.

Authors:  Elena Ciaglia; Valentina Lopardo; Francesco Montella; Albino Carrizzo; Paola Di Pietro; Marco Malavolta; Robertina Giacconi; Fiorenza Orlando; Monica Cattaneo; Paolo Madeddu; Carmine Vecchione; Annibale Alessandro Puca
Journal:  Cell Death Dis       Date:  2022-01-27       Impact factor: 8.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.